Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Surender Mohan Kharbanda, Ph.D., Ph.D.

Concepts (369)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Surender Kharbanda's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Surender Kharbanda has written about over time.
MAP Kinase Kinase Kinase 1, 1 publications between 2000 and 2000, average publication date June 2000. MAP Kinase Kinase 4, 2 publications between 2000 and 2003, average publication date November 2001. Coumarins, 2 publications between 2002 and 2004, average publication date July 2003. Proto-Oncogene Proteins c-abl, 6 publications between 2000 and 2008, average publication date September 2004. Isocoumarins, 4 publications between 2002 and 2006, average publication date September 2004. Apoptosis, 19 publications between 2002 and 2017, average publication date May 2008. Oleanolic Acid, 2 publications between 2006 and 2010, average publication date August 2008. Mucin-1, 32 publications between 2003 and 2018, average publication date January 2010. Antineoplastic Agents, 9 publications between 2002 and 2015, average publication date March 2010. Transcription Factor RelA, 3 publications between 2007 and 2016, average publication date May 2011. Cell Line, Tumor, 25 publications between 2003 and 2020, average publication date July 2011. Oncogene Proteins, 4 publications between 2006 and 2018, average publication date September 2011. Cell Survival, 10 publications between 2005 and 2018, average publication date September 2011. fms-Like Tyrosine Kinase 3, 3 publications between 2010 and 2013, average publication date February 2012. Peptides, 8 publications between 2009 and 2017, average publication date September 2012. Leukemia, Myeloid, Acute, 4 publications between 2010 and 2016, average publication date January 2013. Nanocapsules, 2 publications between 2014 and 2015, average publication date September 2014. Oligopeptides, 6 publications between 2011 and 2018, average publication date November 2014. Carcinoma, Ehrlich Tumor, 4 publications between 2014 and 2015, average publication date January 2015. Nanoparticles, 4 publications between 2014 and 2018, average publication date July 2016.

To see the data from this visualization as text, click here.
Kharbanda's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (369)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.